Central Nervous System Insomnia or Sleep Disorders

Table of Contents

RECENT HIGHLIGHTS AND CHANGES
--Recent Highlights and Changes
UPCOMING PATENT EXPIRES BY THERAPY AREA
Insomnia or Sleep Disorders Pipeline Overview
--% of Projects (By Phase of Development)
--No. of Projects by Phase of Development
--Marketed Products Vs. Pipeline Products
Company Overview - Pipeline Projects
--Company Overview - Pipeline Projects

--Top Companies in late stage Insomnia or Sleep Disorders Projects
--BTG plc
--Barr Pharmaceuticals Inc
--Dainippon Sumitomo Pharma Co., Ltd.
--Cortex Pharmaceuticals Inc
--Eli Lilly & Co
--Dov Pharmaceutical Inc
--Fabre-Kramer Pharmaceuticals, Inc.
--Evotec AG
--Merck & Co Inc
--Intra-Cellular Therapies, Inc.
--
--Neurim Pharmaceuticals Ltd.
--Mylan, Inc.
--Neurogen Corporation
--Neurocrine Biosciences Inc
--Pfizer Inc
--Orexo AB
--Sanofi-Aventis
--Ranbaxy Laboratories Ltd.
--Vanda Pharmaceuticals Inc
--Takeda Pharmaceutical Company Limited

--Top Companies in early stage Insomnia or Sleep Disorders Projects
--Alexza Pharmaceuticals Inc
--Abeille Pharmaceuticals, Inc.
--BiRDS Pharma AG
--BioDelivery Sciences International Inc
--Merck & Co Inc
--Johnson & Johnson
--Neurocrine Biosciences Inc
--Neurim Pharmaceuticals Ltd.
--Pfizer Inc
--Omeros Corporation
--Prestwick Pharmaceuticals, Inc.
--Pherin Pharmaceuticals, Inc.

Pipeline Revenue
--Pipeline Revenue
Full Pipeline View
--Pre Clinical Pipeline View
--Phase I Pipeline View
--Phase II Pipeline View
--Phase III Pipeline View
--Pending Approval Pipeline View
--Approved Pipeline View
--On the Market Pipeline View
--Discovery/Development Pipeline View